Top Conviction Ideas – “Pharmaceutical & Hospitals”
The pharmaceutical universe under our coverage reported Q2FY25 growth of 10.2% year-on-year (YoY) and 1.7% quarteron-quarter (QoQ), driven by...
298 Views
Dr Reddy's - Operationally in Line; Gross Margin Weakness a Clear Negative
Adjusted for multiple one-offs, Dr Reddy’s’ 2QFY25 PAT was in line with our and street estimates. EBITDA was marginally ahead, aided by a sales...
303 Views
Dr Reddy’s Laboratories - Decent Print; Work on Growth Levers Underway
Dr. Reddy’s Laboratories’ (DRL) Q2FY25 performance, adjusted for acquisition-related expenses (INR 561mn) and impairment charge of gNuvaring (INR...
327 Views
Dr Reddy’s Labs - North America/Russia/ROW Drive Earnings
DRRD exhibited robust YoY growth in North America (NA), Russia, and ROW markets and a healthy scale-up in the pharmaceutical services and active...
274 Views
HSIE Results Daily: Titan, ABB India, Mankind Pharma, Dr Reddy’s Laboratories
Consolidated jewellery sales (ex-bullion) grew 27% YoY to INR117.8bn (HSIE: in-line). Gold jewellery demand witnessed a step-up jump post the Jul24...
275 Views